The dichloromethane extract of the air-dried leaves and freeze-dried tubers of Smallanthus sonchifolius afforded ent-kaurenoic acid (1). The structure of 1 was elucidated by extensive 1D and 2D NMR spectroscopy and was found to exhibit significant analgesic and anti-inflammatory activities. Ent-kaurenoic acid (1), dissolved in dimethylsulfoxide, also displayed potential anti-diabetes and anti-toxicity activity. In addition, 1 showed low antimicrobial activities against E. coli, P. aeruginosa, S. aureus, C. albicans and T. mentagrophytes, but was found to be inactive against B. subtilis and A. niger.
the biological activities of ent-kaurenoic acid (1) [1g, 2a,2b] which has been isolated from the CH 2 Cl 2 extract of leaves and tubers of S. sonchifolius.
Analgesic potential of 1: The analgesic potential of Yacon was observed in mice orally treated with 1 (100 mg/kg mouse), followed by a single intraperitoneal injection of 1% glacial acetic acid, one hour after the test drug treatment. Writhing frequency was significantly reduced (P<0.01) in Yacon treated mice, which showed the highest maximum analgesic effect (68.5±19.9%) in comparison with Indomethacin (41.0 ±25.0%) and the negative control (-1.25 x 10 -9 ±25.0). The data further suggested that such a dosage of 1 surpassed the analgesic potential of the commercially available dosage of Indomethacin by 27.6%.
Anti-inflammatory potential of 1: Emigration of inflammatory cells in mice pleural cavity was significantly (P<0.01) reduced one hour after induction of pleurisy in comparison with the control (2.15 x 10 -5 ). Compound 1 treatment of mice effectively reduced pulmonary inflammation by 98.1±2.0%, in a similar manner to that of Diclofenac (85.2±15.9%).
The in-vivo analgesic and anti-inflammatory activities follow comparable responses with the use of Indomethacin and Diclofenac, which are well known analgesic and anti-inflammatory drugs, respectively. The same effect was demonstrated in mice treated with 1, but with a more pronounced analgesic activity in the treated test animals than in the positive control group. The data suggest that the concentration used of 1 is as effective as the commercial dosage of Diclofenac, but is 27.6% more potent than Indomethacin. The dosage of 1 used in the current study was considerably higher than that of the positive control. Reducing the dose of 1 may bring about significant reduction in the analgesic effect of the compound, but the data still suggest that 1 may prove to be as potent as the positive control in blocking nociception. The synthesis of inflammatory mediators (IL-1, TNF-α, histamine, serotonin and prostaglandin) may have been inhibited by reduced vascular permeability of the endothelial cells, thus preventing efficient emigration of neutrophils, followed by monocytes, which later prevented the platelets from interacting with lymphocytes, thereby limiting contact and production of necessary factors to produce specific inflammatory mediators [2c]. The possible reduction of pain-mediator synthesis (histamine, K + ions, prostaglandin and other eicosanoids) may prevent the stimulation of nociceptors lined along the peritoneal cavity.
Anti-diabetes and anti-toxicity activity of 1:
The hypoglycemic potential of Yacon was observed in groups of mice administered with the test drugs (Yacon DCM leaf extract and 1), Solosa and DMSO within a four hour blood glucose measurement period at 30 minutes intervals. Solosa was observed to be a fast acting hypoglycemic agent with a relatively short duration of activity. Solosa was able to reduce blood glucose levels at an average rate of 22.1±15.1% for every 30 minutes of measurement until such time that the reduction had reached its peak, at about one and a half hours from the administration of the hypoglycemic agent ( Figure 1A) . Such a percentage reduction is concomitant with the reported physiological effects of Solosa on blood glucose reduction [2d].
The administration of Yacon DCM leaf extract and 1 share almost the same pattern of blood glucose reduction, with a pronounced depression within one hour after introduction of the test drug. The treatments exhibited an immediate and relatively longer duration of activity in comparison with the positive control (Figure 1 B and C) . The percent blood glucose reduction was found to be significantly different (P<0.05) at the 30 minutes and one hour blood glucose measurement periods. Succeeding percent blood glucose reduction, however, revealed no significant differences (P>0.05). In addition, DMSO demonstrated pronounced hypoglycemic activity ( Figure 1D) . Serendipitously, the current study was able to demonstrate the hypoglycemic effects of DMSO as a physiological response to toxic assault on hepato-pancreatic activity.
Mice administered with DMSO have demonstrated CNS depression (circling, disorientation and jumping behavior), which are obvious signs of intoxication. However, administration of either Yacon DCM leaf A bioactive diterpene from Smallanthus sonchifolius Natural Product Communications Vol. 3 (10) 2008 1665 Figure 2B and C) in mice. Mortality data in the current study revealed that percent mortality in groups of mice treated with 1 have the least percentage mortality after the positive control mice at the end of the five hour observation period, followed by Yacon DCM leaf extract and DMSO, with 0% survival (Figure 2A-D) . The data suggest the possible anti-toxicity activity of 1, as it has effectively reduced the percent mortality in DMSO treated mice.
Antimicrobial potential of 1: Compound 1 displayed low antibacterial activity against E. coli, P. aeruginosa and S. aureus, with activity indices (AI) of 0.2, 0.3 and 0.5, respectively. 1 also had antifungal activity against C. albicans and T. mentagrophytes with AI of 0.3 and 0.9, respectively, but was found to be inactive against B. subtilis and A. niger (Table 1) . 
Experimental

Isolation:
The air-dried leaves of S. sonchifolius (978.5 g) were soaked in CH 2 Cl 2 for three days, then filtered. The filtrate was concentrated under vacuum to afford a crude extract (56.5 g), which was chromatographed using increasing proportions of acetone in CH 2 Cl 2 . The 10% to 40% acetone in CH 2 Cl 2 fractions were combined and rechromatographed (5x) eluting with increasing proportion of EtOAc (1 to 2.5%) in light petroleum, to afford 1 (95 mg). The freeze-dried tubers (1.1 kg) of S. sonchifolius were also extracted and chromatographed to afford 1 (120 mg).
Experimental animals:
A total of 90 male albino mice (Mus musculus L.) of an inbred ICR strain (8 weeks old) weighing 23.0 ±2.0 g were acclimatized for 7 days prior to conducting the bioassay. The animals were housed at the animal containment unit of DLSU-Manila with 12 h daylight and 12 h darkness, with free access to food pellets and water. A 16 h fasting period was conducted prior to each treatment procedure. Either cervical dislocation or injection of 70% ethanol (anti-pleurisity assay) was performed at the end of the animal treatment procedure. All procedures involving animal handling were in accordance with the Philippine Association of Laboratory Animal Science (PALAS) code of practice for care and use of laboratory animals and with administrative order 40 of the Bureau of Animal Industry relative to Republic Act No. 8485.
Acetic acid writhing assay [2e]: Analgesia was tested in mice orally administered with Polysorbate 80 (25 mL/kg BW, Tween-80, AJAX, Finechem Pty. Ltd., Australia), Indomethacin (7.14 mg/kg, Infree, Eisai Co. Ltd., Japan), as the negative and positive controls, respectively, and 1 (100 mg/kg BW), followed by an intraperitoneal injection of 1% acetic acid (Mallinckrodt Chemicals, Pittsburg, New Jersey) 1 h after administration of the drugs. The number of abdominal stretches completed within 10 minutes after injection of 1% glacial acetic acid were counted and presented as % maximum analgesic effect.
Induction of pleurisy and assessment of antiinflammatory activity:
Pleurisy was induced by an intrapleural injection of 1% λ-carageenan (0.15 mL, Marine Development Resources Corporation, Quezon City, Philippines) in normal saline solution into anesthetized male mice [2f]. Polysorbate 80 (25 mL/kg BW), Diclofenac sodium difenax, (7.14 mg/kg BW, GX International, Philippines) and 1 (100 mg/kg BW) were administered orally, 1 h after induction of pleurisy. Inflammatory exudates were collected 1 h after administration of the test drugs from the pleural cavity of the control and drug treated animals (n = 9 per group). Exudate cell smears were fixed in 100% methanol and rinsed in distilled H 2 O. The fixed slides were stained with Giemsa solution [4mg/mL in MeOH:H 2 O (7:3)] and rinsed in tap water. Inflammatory cells were counted and presented as % maximum anti-inflammatory effect.
